Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Pharmacology

  • Article

    No Clear Benefit to the Use of Haloperidol for ICU Delirium

    February 1, 2024

    Dr. Leventhal Clinical question: Does the use of haloperidol versus placebo for delirium in ICU patients improve mortality and increase the chance of hospital discharge at 90 days? Background:...

  • Article

    Abatacept and Infliximab May Improve Mortality in Patients Hospitalized with COVID-19 Pneumonia

    February 1, 2024

    Dr. Rose Clinical question: What immunomodulatory drugs should we use in hospitalized patients with COVID-19 in addition to corticosteroids? Background: Inflammation is a key driver of morbidity...

  • Article

    Clinical Update: RSV Vaccines for Adults

    December 7, 2023

    Respiratory syncytial virus (RSV) is a common seasonal virus that can cause serious illness in children and adults alike. It was first isolated in a group of chimpanzees in 1956 and was originally...

  • Article

    Questions Remain About Nirsevimab’s Impact

    November 16, 2023

    The new monoclonal antibody nirsevimab may radically change incidence and outcomes for respiratory syncytial virus (RSV) infections in young pediatric patients, especially when combined with the...

  • Article

    Real-world Application of Oral Therapy for Infective Endocarditis

    September 1, 2023

    Dr. Chadwick Clinical question: Does oral transitional antibiotic therapy have similar outcomes to intravenous (IV)-only antibiotic treatment for infective endocarditis (IE)? Background: There...

  • Article

    Acute Pain Management

    July 5, 2023

    This case-based session provided hospitalists with expert opinions and evidence-based approaches to navigate challenges when managing acute pain in the inpatient setting. Opioid prescription...

  • Article

    Use of Ketamine in Hospitalized Patients

    July 5, 2023

    Ketamine, a dissociative agent, is listed on the 21st WHO Model List of Essential Medicines for basic health care systems. It first gained U.S. Food and Drug Administration approval as an anesthetic...

  • Article

    Buprenorphine 101: A Quick Start Guide for Every Hospitalist

    July 5, 2023

    In this workshop, the presenters provided an overview of the diagnosis and management of opioid use disorder (OUD) and an introduction to medication for opioid use disorders (MOUD). The presenters...

  • Article

    SER-109, an Oral Microbiome Therapy for rCDI

    April 3, 2023

    Dr. Arobelidze Clinical question: In patients with recurrent Clostridioides difficile infection (rCDI), is the use of oral microbiome therapy associated with reduced risk of recurrence of the...

  • Article

    7-day Antibiotic Treatment is Noninferior to 14 Days in Afebrile Men with UTI

    April 3, 2023

    Dr. Modha Clinical question: Are 14 days of antibiotic treatment better than 7 days in afebrile men with urinary tract infection (UTI)? Background: In the era of antibiotic stewardship, a large...

Previous1 2 3 4 5 6 … 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences